Form 4: Humacyte Director Exercises Stock Options and Disposes of Shares
SEC Form 4
Charles Bruce Green, a director of Humacyte, Inc., exercised stock options and disposed of 600 shares of common stock on May 20, 2024.
Summary
- On May 20, 2024, Charles Bruce Green, a director of Humacyte, Inc., exercised stock options to acquire 600 shares of common stock at a price of $4.09 per share.
- Simultaneously, Green disposed of 600 shares of common stock.
- Following these transactions, Green directly owns 11,800 derivative securities and 1,200 shares of Humacyte common stock.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company directors. It's a standard practice in publicly traded companies.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding insider activity.
Key Dates
| Date | Description |
|---|---|
| 09/15/2023 | Date exercisable for stock options |
| 05/20/2024 | Date of transaction: stock option exercise and share disposal |
| 05/21/2024 | Date of signature |
| 09/15/2032 | Expiration date for stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.